rhIL-11 for the prevention of dose-limiting chemotherapy-induced thrombocytopenia. Oncology (Williston Park) 2000 Sep;14(9 Suppl 8):9-11
Date
10/18/2000Pubmed ID
11033833Scopus ID
2-s2.0-0034278344 (requires institutional sign-in at Scopus site) 9 CitationsAuthor List
Kurzrock RAuthor
Razelle Kurzrock MD Center Associate Director, Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Antineoplastic AgentsBlood Platelets
Colony-Stimulating Factors
Dose-Response Relationship, Drug
Hematopoiesis
Humans
Interleukin-11
Maximum Tolerated Dose
Megakaryocytes
Recombinant Proteins
Thrombocytopenia